Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | VIR |
---|---|---|
09:32 ET | 4986 | 7.43 |
09:34 ET | 7453 | 7.39 |
09:36 ET | 328 | 7.35 |
09:38 ET | 1776 | 7.4 |
09:39 ET | 4417 | 7.43 |
09:41 ET | 1300 | 7.42 |
09:43 ET | 100 | 7.4072 |
09:45 ET | 200 | 7.38 |
09:48 ET | 1006 | 7.4 |
09:50 ET | 540 | 7.4 |
09:52 ET | 500 | 7.405 |
09:54 ET | 100 | 7.41 |
09:56 ET | 1796 | 7.4 |
09:59 ET | 763 | 7.4 |
10:01 ET | 3352 | 7.39 |
10:03 ET | 5813 | 7.405 |
10:06 ET | 21251 | 7.4 |
10:08 ET | 602 | 7.37 |
10:10 ET | 2391 | 7.395 |
10:12 ET | 1813 | 7.42 |
10:14 ET | 836 | 7.41 |
10:15 ET | 500 | 7.39 |
10:17 ET | 424 | 7.39 |
10:19 ET | 956 | 7.39 |
10:21 ET | 1851 | 7.39 |
10:24 ET | 917 | 7.36 |
10:26 ET | 3228 | 7.37 |
10:28 ET | 764 | 7.37 |
10:30 ET | 400 | 7.38 |
10:32 ET | 610 | 7.375 |
10:33 ET | 100 | 7.37 |
10:35 ET | 558 | 7.37 |
10:37 ET | 1286 | 7.35 |
10:39 ET | 3713 | 7.34 |
10:42 ET | 500 | 7.35 |
10:44 ET | 1600 | 7.4 |
10:46 ET | 200 | 7.41 |
10:48 ET | 437 | 7.425 |
10:50 ET | 311 | 7.45 |
10:51 ET | 1600 | 7.47 |
10:53 ET | 962 | 7.46 |
10:57 ET | 3001 | 7.46 |
11:00 ET | 3592 | 7.5 |
11:02 ET | 1431 | 7.49 |
11:04 ET | 2441 | 7.54 |
11:06 ET | 100 | 7.55 |
11:08 ET | 300 | 7.55 |
11:09 ET | 3079 | 7.54 |
11:11 ET | 2642 | 7.55 |
11:13 ET | 778 | 7.535 |
11:18 ET | 1695 | 7.54 |
11:20 ET | 8283 | 7.6 |
11:22 ET | 912 | 7.59 |
11:24 ET | 1313 | 7.575 |
11:26 ET | 200 | 7.58 |
11:27 ET | 1811 | 7.565 |
11:29 ET | 200 | 7.57 |
11:31 ET | 960 | 7.57 |
11:36 ET | 400 | 7.58 |
11:38 ET | 2400 | 7.6 |
11:40 ET | 200 | 7.6 |
11:42 ET | 400 | 7.6 |
11:44 ET | 300 | 7.6 |
11:45 ET | 3126 | 7.62 |
11:47 ET | 4731 | 7.64 |
11:49 ET | 650 | 7.65 |
11:51 ET | 890 | 7.64 |
11:54 ET | 2016 | 7.64 |
11:56 ET | 1100 | 7.65 |
11:58 ET | 2012 | 7.63 |
12:00 ET | 300 | 7.6243 |
12:02 ET | 390 | 7.63 |
12:03 ET | 1400 | 7.62 |
12:05 ET | 1200 | 7.61 |
12:07 ET | 597 | 7.625 |
12:09 ET | 600 | 7.635 |
12:12 ET | 1009 | 7.63 |
12:14 ET | 399 | 7.63 |
12:16 ET | 213 | 7.63 |
12:18 ET | 200 | 7.63 |
12:20 ET | 1959 | 7.61 |
12:21 ET | 200 | 7.61 |
12:23 ET | 1375 | 7.62 |
12:25 ET | 1461 | 7.645 |
12:27 ET | 300 | 7.65 |
12:30 ET | 500 | 7.66 |
12:32 ET | 200 | 7.66 |
12:34 ET | 1100 | 7.645 |
12:36 ET | 1543 | 7.625 |
12:38 ET | 400 | 7.61 |
12:39 ET | 301 | 7.61 |
12:41 ET | 100 | 7.63 |
12:43 ET | 300 | 7.62 |
12:45 ET | 1787 | 7.59 |
12:48 ET | 200 | 7.58 |
12:50 ET | 100 | 7.58 |
12:52 ET | 900 | 7.57 |
12:54 ET | 400 | 7.575 |
12:56 ET | 373 | 7.575 |
12:57 ET | 1443 | 7.555 |
12:59 ET | 100 | 7.54 |
01:01 ET | 1416 | 7.54 |
01:03 ET | 400 | 7.54 |
01:06 ET | 200 | 7.54 |
01:08 ET | 100 | 7.53 |
01:10 ET | 1220 | 7.53 |
01:12 ET | 3631 | 7.55 |
01:14 ET | 1400 | 7.54 |
01:15 ET | 342 | 7.54 |
01:19 ET | 810 | 7.56 |
01:21 ET | 1201 | 7.57 |
01:24 ET | 1200 | 7.57 |
01:26 ET | 427 | 7.57 |
01:28 ET | 400 | 7.57 |
01:30 ET | 300 | 7.575 |
01:32 ET | 2493 | 7.57 |
01:33 ET | 2998 | 7.58 |
01:35 ET | 743 | 7.575 |
01:37 ET | 4804 | 7.565 |
01:39 ET | 3876 | 7.58 |
01:42 ET | 700 | 7.59 |
01:44 ET | 420 | 7.605 |
01:46 ET | 300 | 7.61 |
01:48 ET | 200 | 7.615 |
01:50 ET | 633 | 7.63 |
01:51 ET | 926 | 7.645 |
01:53 ET | 1985 | 7.66 |
01:55 ET | 2160 | 7.67 |
01:57 ET | 2500 | 7.67 |
02:00 ET | 1214 | 7.66 |
02:02 ET | 200 | 7.67 |
02:04 ET | 1410 | 7.675 |
02:06 ET | 2200 | 7.69 |
02:08 ET | 4962 | 7.71 |
02:09 ET | 3200 | 7.7 |
02:11 ET | 100 | 7.695 |
02:13 ET | 704 | 7.7 |
02:15 ET | 100 | 7.71 |
02:18 ET | 400 | 7.71 |
02:20 ET | 200 | 7.705 |
02:22 ET | 5362 | 7.72 |
02:24 ET | 1400 | 7.74 |
02:26 ET | 700 | 7.7499 |
02:27 ET | 3674 | 7.73 |
02:29 ET | 1898 | 7.71 |
02:31 ET | 400 | 7.725 |
02:33 ET | 3606 | 7.73 |
02:36 ET | 800 | 7.7301 |
02:38 ET | 1823 | 7.75 |
02:40 ET | 1100 | 7.7529 |
02:42 ET | 500 | 7.76 |
02:44 ET | 700 | 7.76 |
02:45 ET | 1559 | 7.76 |
02:47 ET | 900 | 7.75 |
02:49 ET | 379 | 7.76 |
02:51 ET | 1000 | 7.75 |
02:54 ET | 2463 | 7.74 |
02:56 ET | 2080 | 7.7273 |
02:58 ET | 1300 | 7.72 |
03:00 ET | 1100 | 7.725 |
03:02 ET | 3322 | 7.73 |
03:03 ET | 1487 | 7.735 |
03:07 ET | 500 | 7.73 |
03:09 ET | 1519 | 7.75 |
03:12 ET | 1067 | 7.74 |
03:14 ET | 3717 | 7.74 |
03:16 ET | 1673 | 7.725 |
03:18 ET | 200 | 7.72 |
03:20 ET | 3161 | 7.745 |
03:21 ET | 631 | 7.75 |
03:23 ET | 985 | 7.74 |
03:25 ET | 1200 | 7.76 |
03:27 ET | 3600 | 7.74 |
03:30 ET | 600 | 7.7442 |
03:32 ET | 1217 | 7.75 |
03:34 ET | 9625 | 7.78 |
03:36 ET | 1972 | 7.775 |
03:38 ET | 1743 | 7.785 |
03:39 ET | 300 | 7.79 |
03:41 ET | 16649 | 7.775 |
03:43 ET | 700 | 7.775 |
03:45 ET | 7645 | 7.775 |
03:48 ET | 9066 | 7.74 |
03:50 ET | 2533 | 7.715 |
03:52 ET | 8018 | 7.725 |
03:54 ET | 2308 | 7.705 |
03:56 ET | 4300 | 7.7 |
03:57 ET | 18301 | 7.655 |
03:59 ET | 185086 | 7.68 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Vir Biotechnology Inc | 1.0B | -2.1x | --- |
Prothena Corporation PLC | 895.4M | -16.5x | --- |
Zymeworks Inc | 877.4M | -8.2x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -4.7x | --- |
Gyre Therapeutics Inc | 1.1B | -13.7x | --- |
WAVE Life Sciences Ltd | 1.2B | -15.2x | --- |
Vir Biotechnology, Inc. is an immunology company, which is focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions. The Company's clinical development pipeline consists of product candidates targeting hepatitis delta virus (HDV), hepatitis B virus (HBV), and human immunodeficiency virus (HIV). It also has several preclinical candidates in its pipeline including those targeting influenza A and B, COVID-19, respiratory syncytial virus and human metapneumovirus (RSV and MPV), and human papillomavirus (HPV). The Company's pipeline includes VIR-1949, VIR-7229, VIR-2981, VIR-8190, and HIV Cure. It also engaged in developing tobevibart, a monoclonal antibody also known as VIR-3434, and Elebsiran, an siRNA also known as VIR-2218, for the treatment and suppression of chronic HDV. Its Elebsiran is an investigational HBV-targeted siRNA that reduces HBsAg, a protein which is required for the HDV viral life cycle.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
---|---|
Revenue (TTM) | $78.9M |
Shares Outstanding | 136.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.46 |
EPS | $-3.58 |
Book Value | $11.80 |
P/E Ratio | -2.1x |
Price/Sales (TTM) | 13.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -715.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.